Molecular Innovations Toward Theranostics of Aggressive Prostate Cancer
Abstract
The efforts during this period include 1) the exploration of dendrimers that provide water solubility in the presence of hydrophobic peptides (a limitation encountered in the previous period), 2) the production of dendrimers with a DOTA-chelating ligand that can host the imaging agent, and 3) production of candidate theranostic dendrimer-peptide platforms for the evaluation of biological activity. A new conjugation strategy has been developed and shown to be useful for making the proposed multivalent conjugates. Samples continue to be submitted to our collaborators for biological evaluation.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 2014
- Accession Number
- ADA622389
Entities
People
- Eric E Simanek
Organizations
- Texas Christian University